Adherence to Anti-Retroviral Therapy and its Associated Factors Among Women Living with HIV/AIDS in a Teaching Hospital in Ibadan, Nigeria
DOI:
https://doi.org/10.71637/tnhj.v25i1.929Keywords:
Women, Adherence, Antiretroviral therapy, Childbearing ageAbstract
Background: Optimal adherence to antiretroviral therapy requires the collaboration of health care workers with Background: Optimal adherence to antiretroviral therapy requires the collaboration of health care workers with health care receivers and a well-designed integration of several disciplines to ensure its success. This study determined the adherence to antiretroviral therapy and factors contributing to non-adherence among women living with HIV/AIDS.
Methods: This study adopted a descriptive cross-sectional design. A standardized tool on adherence level by Morisky tool was used to collect data from 132 women of childbearing age. The data were coded and analyzed using the Statistical Package of Social Sciences (SPSS), version 20.0 at 0.05 level of significance.
Results: Majority of participants, 67 (50.8%), were secondary school graduates, 80.3% identified as Yoruba, and 63.6% were Christians. Their adherence to antiretroviral therapy (ART) 64.4%, was significantly below the international standard of 95%. Additionally, most respondents (87.9%) reported experiencing adverse effects from the medication. More than half of the respondents (58.3%) experienced mild psychological symptoms while 3% experienced severe psychological symptoms. There were no significant association between the participants’ educational qualification and their adherence level, (p ≥0.34), between marital status and their adherence to antiretroviral therapy, (p ≥0.23) and between participants’ family types and their adherence to antiretroviral therapy, (p ≥0.19).
Conclusion: The findings of this study underscore the urgent need for multifaceted approaches to improve antiretroviral therapy adherence. Beyond targeted training programmes, there is a necessity for systemic interventions that could address the social, psychological, and cultural factors influencing adherence. Stakeholders, and support networks, must collaborate to create supportive environments to improve adherence.
Downloads
References
1. UNAIDS. UNAIDS Country Factsheets. 2018 , Available from: http://www.unaids.org/sites/default/files/media_asset/JC2434_WorldAIDSday_results_en_1.pdf
2. Abayomi JA, Olanrewaju M, Gbadebo OO. Explaining adherence to HAART among patients living with HIV/AIDS in Nigeria: Behavioral theory analysis. Clin Immunol Res. 2017;1(1):1-8.
3. Liranso GS, Mohan SS, Eyerus A. The psychosocial factors influencing HIV/AIDS antiretroviral treatment adherence. J AIDS HIV Infect. 2016;2(2):205.
4. Selamu LG, Singhe MS, Assefa E. The psychosocial factors influencing antiretroviral treatment adherence. J Clin Res HIV AIDS Prev. 2017;3(1):31-39. doi: 10.14302/issn.2324-7339.jcrhap-16-1316.
5. Pennington J. HIV/AIDS in Nigeria. AVERT; 2018. Available from: http://www.avert.org/about-hiv-aids
6. Taiwo MO, Bickersteth FT. Association between psychological well-being and antiretroviral therapy adherence in North-Central, Nigeria. Am J Appl Psychol. 2017;5(1):18-24.
7. Biressaw S, Abegaz WE, Abebe M, Taye WA, Belay M. Adherence to antiretroviral therapy and associated factors among HIV-infected children in Ethiopia: Unannounced home-based pill count versus caregivers’ report. BMC Pediatr. 2013;13:132. Available from: http://www.biomedcentral.com/1471-2431/13/132
8. Beshir M, Tesfaye A. Factors affecting adherence to antiretroviral treatment among patients living with HIV/AIDS in Bale Zone, South Eastern Ethiopia. J AIDS HIV Res. 2016;9(3):67-73.
9. Adeniyi OV, Ajayi AI, Moyaki MG, Ter Goon D, Avramovic G, Lambert J. High rate of unplanned pregnancy in the context of integrated family planning and HIV care services in South Africa. BMC Health Serv Res. 2018;18(1):1-8.
10. Yaya E. BMC Public Health. 2014;14:1308. Available from: http://www.biomedcentral.com/1471-2458/14/1308
11. Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S. Adherence to antiretroviral therapy among people living with HIV. North Am J Med Sci. 2013;5(3):220
12. Bijker A, et al. Psychological therapy for HIV in sub-Saharan Africa and Asia: A comparative analysis of two regional cohorts. J Int AIDS Soc. 2017;20(1):21218.
13. Delicio AM, Lajos GJ, Amaral E, Lopes F, Cavichiolli F, Myioshi I, Milanez H. Adverse effects of antiretroviral therapy in pregnant women infected with HIV in Brazil from 2000 to 2015: A cohort study. BMC Infect Dis. 2018;18(1):485.
14. Motsoeneng B. What to do when a pregnant woman tests HIV positive [Internet]. Health-e News; 2016. Available from: http://m.health24.com/
15. Sax PE, Wohl D, Yin MT, Post F, DeJesus E, Saag M, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: Two randomised, double-blind, phase 3, non-inferiority trials. Lancet. 2015 Jun 27;385(9987):2606-15.
16. Karania MK, Kirimi C. Psychosocial determinants of adherence to antiretroviral drugs among women living with HIV and AIDS in Huruma, Nairobi County, Kenya. Int J Sci Basic Appl Res. 2015;19(1):188-212.
17. Heestermans T, Browne JL, Aitken SC, et al. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: A systematic review. BMJ Glob Health. 2016;1:e000125.
18. Weaver ER, Pane M, Wandra T, Windiyaningsih C, Herlina, et al. Factors that influence adherence to antiretroviral treatment in an urban population, Jakarta, Indonesia. PLoS One. 2014;9(9):e107543. doi:10.1371/journal.pone.0107543.
19. Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, et al. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS One. 2014;9(11):e111421.
20. Oginni MO, Aremu OO, Olowokere AE, Ayamolowo SJ, Komolafe AO. Adherence to HIV care among HIV-positive pregnant women in Nigeria. Afr J Midwifery Womens Health. 2018;12(1). Available from: https://doi.org/10.12968/ajmw.2018.12.1.2
Published
Issue
Section
License
Copyright (c) 2025 Grace Ibezimoh, Grace Ademuyiwa, Ikenna Ojiegbe, Miracle Ndikom, Chizoma Ndikom

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.